170 related articles for article (PubMed ID: 30320239)
1. Predictive Models for Acute Oral Systemic Toxicity: A Workshop to Bridge the Gap from Research to Regulation.
Kleinstreuer NC; Karmaus A; Mansouri K; Allen DG; Fitzpatrick JM; Patlewicz G
Comput Toxicol; 2018 Nov; 8(11):21-24. PubMed ID: 30320239
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Acute Oral Systemic Toxicity Using a Multifingerprint Similarity Approach.
Alberga D; Trisciuzzi D; Mansouri K; Mangiatordi GF; Nicolotti O
Toxicol Sci; 2019 Feb; 167(2):484-495. PubMed ID: 30371864
[TBL] [Abstract][Full Text] [Related]
3. Exploring current read-across applications and needs among selected U.S. Federal Agencies.
Patlewicz G; Lizarraga LE; Rua D; Allen DG; Daniel AB; Fitzpatrick SC; Garcia-Reyero N; Gordon J; Hakkinen P; Howard AS; Karmaus A; Matheson J; Mumtaz M; Richarz AN; Ruiz P; Scarano L; Yamada T; Kleinstreuer N
Regul Toxicol Pharmacol; 2019 Aug; 106():197-209. PubMed ID: 31078681
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the performance of selected (Q)SARs/expert systems for predicting acute oral toxicity.
Nelms MD; Karmaus AL; Patlewicz G
Comput Toxicol; 2020 Nov; 16():. PubMed ID: 33163737
[TBL] [Abstract][Full Text] [Related]
5. CATMoS: Collaborative Acute Toxicity Modeling Suite.
Mansouri K; Karmaus AL; Fitzpatrick J; Patlewicz G; Pradeep P; Alberga D; Alepee N; Allen TEH; Allen D; Alves VM; Andrade CH; Auernhammer TR; Ballabio D; Bell S; Benfenati E; Bhattacharya S; Bastos JV; Boyd S; Brown JB; Capuzzi SJ; Chushak Y; Ciallella H; Clark AM; Consonni V; Daga PR; Ekins S; Farag S; Fedorov M; Fourches D; Gadaleta D; Gao F; Gearhart JM; Goh G; Goodman JM; Grisoni F; Grulke CM; Hartung T; Hirn M; Karpov P; Korotcov A; Lavado GJ; Lawless M; Li X; Luechtefeld T; Lunghini F; Mangiatordi GF; Marcou G; Marsh D; Martin T; Mauri A; Muratov EN; Myatt GJ; Nguyen DT; Nicolotti O; Note R; Pande P; Parks AK; Peryea T; Polash AH; Rallo R; Roncaglioni A; Rowlands C; Ruiz P; Russo DP; Sayed A; Sayre R; Sheils T; Siegel C; Silva AC; Simeonov A; Sosnin S; Southall N; Strickland J; Tang Y; Teppen B; Tetko IV; Thomas D; Tkachenko V; Todeschini R; Toma C; Tripodi I; Trisciuzzi D; Tropsha A; Varnek A; Vukovic K; Wang Z; Wang L; Waters KM; Wedlake AJ; Wijeyesakere SJ; Wilson D; Xiao Z; Yang H; Zahoranszky-Kohalmi G; Zakharov AV; Zhang FF; Zhang Z; Zhao T; Zhu H; Zorn KM; Casey W; Kleinstreuer NC
Environ Health Perspect; 2021 Apr; 129(4):47013. PubMed ID: 33929906
[TBL] [Abstract][Full Text] [Related]
6. A new path forward: the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).
Casey W; Jacobs A; Maull E; Matheson J; Clarke C; Lowit A
J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):170-3. PubMed ID: 25836963
[TBL] [Abstract][Full Text] [Related]
7. Integrated QSAR Models to Predict Acute Oral Systemic Toxicity.
Ballabio D; Grisoni F; Consonni V; Todeschini R
Mol Inform; 2019 Aug; 38(8-9):e1800124. PubMed ID: 30549437
[TBL] [Abstract][Full Text] [Related]
8. Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies.
Strickland J; Clippinger AJ; Brown J; Allen D; Jacobs A; Matheson J; Lowit A; Reinke EN; Johnson MS; Quinn MJ; Mattie D; Fitzpatrick SC; Ahir S; Kleinstreuer N; Casey W
Regul Toxicol Pharmacol; 2018 Apr; 94():183-196. PubMed ID: 29408321
[TBL] [Abstract][Full Text] [Related]
9. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
Stokes WS; Schechtman LM; Hill RN
Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
[TBL] [Abstract][Full Text] [Related]
10. Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing.
Hamm J; Sullivan K; Clippinger AJ; Strickland J; Bell S; Bhhatarai B; Blaauboer B; Casey W; Dorman D; Forsby A; Garcia-Reyero N; Gehen S; Graepel R; Hotchkiss J; Lowit A; Matheson J; Reaves E; Scarano L; Sprankle C; Tunkel J; Wilson D; Xia M; Zhu H; Allen D
Toxicol In Vitro; 2017 Jun; 41():245-259. PubMed ID: 28069485
[TBL] [Abstract][Full Text] [Related]
11. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
Schechtman LM
ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
[TBL] [Abstract][Full Text] [Related]
12. The FDA's regulatory role in the ICCVAM process.
Schechtman LM; Stokes WS
Altern Lab Anim; 2004 Jun; 32 Suppl 1B():663-8. PubMed ID: 23581155
[TBL] [Abstract][Full Text] [Related]
13. Transitioning the Generalised Read-Across approach (GenRA) to quantitative predictions: A case study using acute oral toxicity data.
Helman G; Shah I; Patlewicz G
Comput Toxicol; 2019 Nov; 12(November 2019):. PubMed ID: 33623834
[TBL] [Abstract][Full Text] [Related]
14. Skin sensitization testing needs and data uses by US regulatory and research agencies.
Strickland J; Daniel AB; Allen D; Aguila C; Ahir S; Bancos S; Craig E; Germolec D; Ghosh C; Hudson NL; Jacobs A; Lehmann DM; Matheson J; Reinke EN; Sadrieh N; Vukmanovic S; Kleinstreuer N
Arch Toxicol; 2019 Feb; 93(2):273-291. PubMed ID: 30377734
[TBL] [Abstract][Full Text] [Related]
15. Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use.
Corvi R; Ahr HJ; Albertini S; Blakey DH; Clerici L; Coecke S; Douglas GR; Gribaldo L; Groten JP; Haase B; Hamernik K; Hartung T; Inoue T; Indans I; Maurici D; Orphanides G; Rembges D; Sansone SA; Snape JR; Toda E; Tong W; van Delft JH; Weis B; Schechtman LM
Environ Health Perspect; 2006 Mar; 114(3):420-9. PubMed ID: 16507466
[TBL] [Abstract][Full Text] [Related]
16. IVIVE: Facilitating the Use of
Chang X; Tan YM; Allen DG; Bell S; Brown PC; Browning L; Ceger P; Gearhart J; Hakkinen PJ; Kabadi SV; Kleinstreuer NC; Lumen A; Matheson J; Paini A; Pangburn HA; Petersen EJ; Reinke EN; Ribeiro AJS; Sipes N; Sweeney LM; Wambaugh JF; Wange R; Wetmore BA; Mumtaz M
Toxics; 2022 May; 10(5):. PubMed ID: 35622645
[TBL] [Abstract][Full Text] [Related]
17. ICCVAM evaluation of the murine local lymph node assay. The ICCVAM review process.
Sailstad DM; Hattan D; Hill RN; Stokes WS
Regul Toxicol Pharmacol; 2001 Dec; 34(3):249-57. PubMed ID: 11754529
[TBL] [Abstract][Full Text] [Related]
18. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
19. ECVAM-ICCVAM: prospects for future collaboration.
Schechtman LM; Stokes WS
Altern Lab Anim; 2002 Dec; 30 Suppl 2():227-36. PubMed ID: 12513682
[TBL] [Abstract][Full Text] [Related]
20. Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report.
Clippinger AJ; Allen D; Jarabek AM; Corvaro M; Gaça M; Gehen S; Hotchkiss JA; Patlewicz G; Melbourne J; Hinderliter P; Yoon M; Huh D; Lowit A; Buckley B; Bartels M; BéruBé K; Wilson DM; Indans I; Vinken M
Toxicol In Vitro; 2018 Apr; 48():53-70. PubMed ID: 29277654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
